13F Pro

SEC Form 4 reporting owner

Rallis Chris A

Rallis Chris A has filed 3 Form 4 transactions reported between May 11, 2026 and June 10, 2026, as a reporting owner of FENNEC PHARMACEUTICALS INC..

Name as filed: RALLIS CHRIS A

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$59K
1 lines
Companies
1
with Form 4 filings
Latest transaction
Jun 10, 2026
transaction date

Roles and reported holdings

  • FENCFENNEC PHARMACEUTICALS INC.
    May 11, 2026 – Jun 10, 2026

    Reporting owner

    Held directly63,077 sh as of May 11, 2026 · Form 4

    24 months: $59K sold

Transaction history

All 3 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Jun 10, 2026FENCGrant or awardCode A · direct20,000$174K@ $8.70Form 4
May 11, 2026FENCOpen-market saleCode S · direct8,346$59K@ $7.04Form 4
May 11, 2026FENCOption exerciseCode M · direct14,344$35K@ $2.44Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.